Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chloramphenicol Monopalmitate
2. Chloramphenicol Palmitate, Diammonium Salt
3. Chloramphenicol Palmitate, Monoammonium Salt
4. Chloramphenicol Palmitate, Monopalmitate
1. 530-43-8
2. Detreopal
3. Cap-palmitate
4. Chloromycetin Palmitate
5. Chloramphenicol Monopalmitate
6. Chlorambon
7. Clorolifarina
8. (2r,3r)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl Palmitate
9. Chebi:3605
10. 43vu4207nw
11. Chloramphenicol Palmitate Polymorph A
12. Nsc-756675
13. Chloramphenicol Palmitate Nonpolymorph A
14. Ncgc00159489-04
15. [(2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] Hexadecanoate
16. 125637-16-3
17. (2r,3r)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl Hexadecanoate
18. Rel-(2r,3r)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl Palmitate
19. Hexadecanoic Acid, 2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl Ester, (r-(r*,r*))-
20. Cap-p
21. Unii-43vu4207nw
22. Chloramphenicol Palmitate [jan]
23. Chloramphenicol Palmitate (ester)
24. Einecs 208-477-9
25. Mfcd00083597
26. Brn 2826438
27. Chloramphenicol Palmitate [usp:ban:jan]
28. Chloramphenicol-palmitate
29. Chloramphenicoli Palmitas
30. Ai3-51715
31. Chembl1506
32. Dsstox_cid_28625
33. Dsstox_rid_82895
34. Dsstox_gsid_48699
35. Chloromycetin Palmitate (tn)
36. 4-13-00-02753 (beilstein Handbook Reference)
37. Schembl193727
38. Dtxsid9048699
39. Hy-b1599
40. Zinc8214521
41. Tox21_113094
42. Chloramphenicol Palmitate [mi]
43. Akos025401796
44. Chloramphenicol Palmitate (jp17/usp)
45. Bcp9000521
46. Db14658
47. Nsc 756675
48. Chloramphenicol Palmitate [mart.]
49. Chloramphenicol Palmitate [vandf]
50. Ncgc00348371-01
51. Ac-25653
52. Cas-530-43-8
53. Chloramphenicol Palmitate [who-dd]
54. Chloramphenicol Palmitate [who-ip]
55. D-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide Alpha-palmitate
56. Hexadecanoic Acid, 2-((dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl Ester, (r-(r*,r*))-
57. Cs-0013525
58. Chloramphenicol Palmitate [green Book]
59. Chloramphenicol Palmitate [ep Monograph]
60. Chloramphenicol Palmitate [orange Book]
61. Chloramphenicol Palmitate [usp Impurity]
62. D01072
63. T71010
64. Chloramphenicol Palmitate [usp Monograph]
65. Chloramphenicoli Palmitas [who-ip Latin]
66. A829360
67. Chloramphenicol Palmitate Polymorph A [usp-rs]
68. Q27106147
69. Chloramphenicol Palmitate Nonpolymorph A [usp-rs]
70. Chloramphenicol Palmitate, Vetranal(tm), Analytical Standard
71. (2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propylhexadecanoate
72. 2,2-dichloro-n-[(1r,2r)-1,3-dihydroxy-1-(4-nitrophenyl)-2-propyl]acetamide Palmitate
73. Chloramphenicol Palmitate Polymorph A, United States Pharmacopeia (usp) Reference Standard
74. Chloramphenicol Palmitate, United States Pharmacopeia (usp) Reference Standard
75. D-(-)-threo-2-dichloroacetamido-1-(4-nitrophenyl)-1,3-propanediol Palmitate
76. Chloramphenicol Palmitate Nonpolymorph A, United States Pharmacopeia (usp) Reference Standard
77. D-threo-(-)-2,2-dichloro-n-(.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenethyl)acetamide .alpha.-palmitate
78. Hexadecanoic Acid, (2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl Ester
79. Hexadecanoic Acid, 2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl) Propyl Ester, (r-(r*,r*))-
80. Palmitic Acid, Alpha-ester With D-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide
| Molecular Weight | 561.5 g/mol |
|---|---|
| Molecular Formula | C27H42Cl2N2O6 |
| XLogP3 | 9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 21 |
| Exact Mass | 560.2419925 g/mol |
| Monoisotopic Mass | 560.2419925 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 639 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
Regulatory Info :
Registration Country : Canada
CHLORAMPHENICOL (CHLORAMPHENICOL PALMITATE)
Brand Name : CHLOR PALM 250 (CHLORAMPHENICOL PALMITATE ORAL SUSPENSION)
Dosage Form : SUSPENSION
Dosage Strength : 50MG/ML
Packaging : 60ML
Approval Date :
Application Number : 798363
Regulatory Info :
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Chloramphenicol Palmitate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chloramphenicol Palmitate, including repackagers and relabelers. The FDA regulates Chloramphenicol Palmitate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chloramphenicol Palmitate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chloramphenicol Palmitate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chloramphenicol Palmitate supplier is an individual or a company that provides Chloramphenicol Palmitate active pharmaceutical ingredient (API) or Chloramphenicol Palmitate finished formulations upon request. The Chloramphenicol Palmitate suppliers may include Chloramphenicol Palmitate API manufacturers, exporters, distributors and traders.
click here to find a list of Chloramphenicol Palmitate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chloramphenicol Palmitate DMF (Drug Master File) is a document detailing the whole manufacturing process of Chloramphenicol Palmitate active pharmaceutical ingredient (API) in detail. Different forms of Chloramphenicol Palmitate DMFs exist exist since differing nations have different regulations, such as Chloramphenicol Palmitate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chloramphenicol Palmitate DMF submitted to regulatory agencies in the US is known as a USDMF. Chloramphenicol Palmitate USDMF includes data on Chloramphenicol Palmitate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chloramphenicol Palmitate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chloramphenicol Palmitate suppliers with USDMF on PharmaCompass.
A Chloramphenicol Palmitate written confirmation (Chloramphenicol Palmitate WC) is an official document issued by a regulatory agency to a Chloramphenicol Palmitate manufacturer, verifying that the manufacturing facility of a Chloramphenicol Palmitate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chloramphenicol Palmitate APIs or Chloramphenicol Palmitate finished pharmaceutical products to another nation, regulatory agencies frequently require a Chloramphenicol Palmitate WC (written confirmation) as part of the regulatory process.
click here to find a list of Chloramphenicol Palmitate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chloramphenicol Palmitate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chloramphenicol Palmitate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chloramphenicol Palmitate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chloramphenicol Palmitate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chloramphenicol Palmitate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chloramphenicol Palmitate suppliers with NDC on PharmaCompass.
Chloramphenicol Palmitate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chloramphenicol Palmitate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chloramphenicol Palmitate GMP manufacturer or Chloramphenicol Palmitate GMP API supplier for your needs.
A Chloramphenicol Palmitate CoA (Certificate of Analysis) is a formal document that attests to Chloramphenicol Palmitate's compliance with Chloramphenicol Palmitate specifications and serves as a tool for batch-level quality control.
Chloramphenicol Palmitate CoA mostly includes findings from lab analyses of a specific batch. For each Chloramphenicol Palmitate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chloramphenicol Palmitate may be tested according to a variety of international standards, such as European Pharmacopoeia (Chloramphenicol Palmitate EP), Chloramphenicol Palmitate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chloramphenicol Palmitate USP).
LOOKING FOR A SUPPLIER?
